메뉴 건너뛰기




Volumn 275, Issue 48, 2000, Pages 37702-37711

Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutants and rescues wild-type caveolin-3

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CAVEOLIN 3; LACTACYSTIN; MG 115; MUTANT PROTEIN; PROTEASOME; PROTEASOME INHIBITOR; STRUCTURAL PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

EID: 0034531315     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.M006657200     Document Type: Article
Times cited : (90)

References (65)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.